The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been the primary target of many drug discovery
Read more
Receptor
Scientists review current knowledge of the role of calcium-sensing receptor in immune cells
In a new publication from Cardiovascular Innovations and Applications, Wenxiu Liu, Yutong Guo, Yue Liu, Jiaxing Sun and Xinhua Yin
Read more
Repurposed heart and flu drugs that protect platelets improve survival of septic mice
Despite continued improvements in antibiotics and hospital intensive care, staph sepsis -; a bloodstream infection caused by Staphylococcus aureus bacteria
Read more
SARS-CoV-2 in wastewater may pose risks to marine mammals
Endangered marine mammals — seals, dolphins, whales, and otters — are almost as vulnerable as humans in becoming infected from
Read more
flagyl kansas
The ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led
Read more
Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19
A recent study, currently available on the bioRxiv* preprint server, indicates that a pair of dual-action monoclonal antibodies derived from
Read more
Antibodies to SARS-CoV-2 spike protein and RBD detected in saliva of mRNA-vaccine recipients
Vaccines are very important in controlling the coronavirus disease 2019 (COVID-19) pandemic. Two highly effective mRNA vaccines are available in
Read more
Researcher find an emergent SARS-CoV-2 variant in California
Researchers have found a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant in California, USA. This variant is more
Read more
Neutralizing antibodies may be evolving to keep up with SARS-CoV-2 mutations
Viruses evolve under increased pressure, and new research from The Rockefeller University and University of Massachusetts Medical School in the
Read more
Optimized SARS-CoV-2 vaccine candidate could be less reactogenic, say researchers
A new study, released as a preprint on the bioRxiv* server, reports an optimized coronavirus disease 2019 (COVID-19) vaccine candidate,
Read more